logo
Plus   Neg
Share
Email

CVS Health Raises, Narrows 2019 Adj. EPS Guidance - Quick Facts

CVS Health Corp. (CVS) raised and narrowed its fiscal 2019 adjusted earnings per share guidance range to $6.97 to $7.05 from $6.89 to $7.00. The company also raised and narrowed adjusted operating income guidance range to $15.22 billion to $15.40 billion from $15.16 billion to $15.36 billion. Analysts polled by Thomson Reuters expect the company to report profit per share of $6.98. Analysts' estimates typically exclude special items.

For the third-quarter, adjusted earnings per share was $1.84 compared to $1.73, a year ago. On average, 24 analysts polled by Thomson Reuters expected the company to report profit per share of $1.77, for the quarter.

Third-quarter total revenues increased to $64.81 billion from $47.49 billion, prior year. Analysts expected revenue of $62.99 billion, for the quarter. Adjusted revenues increased 37.1 percent. Revenue growth was primarily driven by the impact of the Aetna Acquisition, as well as increased volume and brand name drug price inflation in both the Pharmacy Services and Retail/LTC segments.

Shares of CVS Health Corp. were up 3% in pre-market trade on Wednesday.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Airbnb has introduced few new rules to control parties and nuisances amidst the backlash the service received after the Halloween shooting at an Airbnb rental in a San Francisco. San Francisco-based Airbnb said it is banning "open invite" parties at all of its accommodations. The company is also banning... The U.S. Food and Drug Administration has approved three generic versions of Novartis' Gilenya capsule for treating relapsing forms of multiple sclerosis. "Approving safe and effective generics so patients have more treatment options continues to be a priority for the FDA," said Janet Woodcock, director... Shares of Upscale furniture chain RH (RH) are on a tear, on the heels of an upbeat annual forecast. Today, the stock set a new all-time high of $239.88.The stock is up more than 20% from its Dec 3 opening price of $196.66, and currently trading at $237.8, and nearly three-times its 52-week low of $84.11....
Follow RTT
>